S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
The “Perfect Storm” for Gold (Ad)
Stock market today: Wall Street drifts to a mixed finish as yields tick higher
How major US stock indexes fared Thursday, 4/18/2024
The Best AI Stock to Own in the World Today is Trading for Just $25 (Ad)
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
1970’s computer coder issues shocking A.I. warning (Ad)
These are the Top 4 Stocks for Buybacks in 2024
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
The “Perfect Storm” for Gold (Ad)
Stock market today: Wall Street drifts to a mixed finish as yields tick higher
How major US stock indexes fared Thursday, 4/18/2024
The Best AI Stock to Own in the World Today is Trading for Just $25 (Ad)
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
1970’s computer coder issues shocking A.I. warning (Ad)
These are the Top 4 Stocks for Buybacks in 2024
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
The “Perfect Storm” for Gold (Ad)
Stock market today: Wall Street drifts to a mixed finish as yields tick higher
How major US stock indexes fared Thursday, 4/18/2024
The Best AI Stock to Own in the World Today is Trading for Just $25 (Ad)
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
1970’s computer coder issues shocking A.I. warning (Ad)
These are the Top 4 Stocks for Buybacks in 2024
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
The “Perfect Storm” for Gold (Ad)
Stock market today: Wall Street drifts to a mixed finish as yields tick higher
How major US stock indexes fared Thursday, 4/18/2024
The Best AI Stock to Own in the World Today is Trading for Just $25 (Ad)
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
1970’s computer coder issues shocking A.I. warning (Ad)
These are the Top 4 Stocks for Buybacks in 2024
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China
Free Trial
TSE:PMN

ProMIS Neurosciences (PMN) Stock Price, News & Analysis

→ The “Perfect Storm” for Gold (From Gold Safe Exchange) (Ad)
Free PMN Stock Alerts
Compare
Today's Range
N/A
50-Day Range
C$6.00
▼
C$6.00
52-Week Range
N/A
Volume
19,701 shs
Average Volume
3,327 shs
Market Capitalization
C$51.48 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Stock AnalysisEarningsHeadlinesInsider Trades
PMN stock logo

About ProMIS Neurosciences Stock (TSE:PMN)

ProMIS Neurosciences, Inc. discovers and develops antibody therapies and therapeutic vaccines neurodegenerative diseases and other misfolded protein diseases in Canada. The company's proprietary discovery platform comprises ProMIS and Collective Coordinates algorithms to predict novel targets known as disease specific epitopes on the molecular surface of misfolded proteins. Its lead product candidates include PMN310, a monoclonal antibody (mAb) for toxic oligomers in AD; PMN267, a TDP-43; and PMN442, a mAb targeting toxic a-syn oligomers and seeding fibrils. The company was formerly known as Amorfix Life Sciences Ltd. and changed its name to ProMIS Neurosciences, Inc. in July 2015. ProMIS Neurosciences, Inc. was incorporated in 2004 and is headquartered in Toronto, Canada.

PMN Stock News Headlines

April 1, 2024 | msn.com
PMN Stock Earnings: ProMIS Neurosciences Beats EPS for Q4 2023
February 22, 2024 | finance.yahoo.com
ProMIS Neurosciences to Present at the 2024 BIO CEO & Investor Conference
April 18, 2024 | Gold Safe Exchange (Ad)
The “Perfect Storm” for Gold
Gold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025.
February 1, 2024 | msn.com
Nerve stimulation plus physical rehabilitation may boost recovery of arm and hand function
January 8, 2024 | markets.businessinsider.com
ProMIS Neurosciences Issues Letter to Shareholders
December 20, 2023 | finanznachrichten.de
ProMIS Neurosciences Inc.: ProMIS Neurosciences Announces Publication on Novel Target for ALS
November 20, 2023 | markets.businessinsider.com
ProMIS Neurosciences Doses First Subjects in Phase 1a Clinical Trial of PMN310 to Treat Alzheimer’s Disease
November 14, 2023 | finance.yahoo.com
ProMIS Neurosciences Announces Third Quarter 2023 Financial Results and Recent Highlights
April 18, 2024 | Gold Safe Exchange (Ad)
The “Perfect Storm” for Gold
Gold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025.
September 8, 2023 | finance.yahoo.com
ProMIS Neurosciences Closes $20.4 Million Private Placement Financing
August 22, 2023 | marketwatch.com
ProMIS Neurosciences Shares Jump on $20.4 Million Private Placement
August 15, 2023 | finanznachrichten.de
ProMIS Neurosciences Inc.: ProMIS Neurosciences Announces Second Quarter 2023 Financial Results and Recent Highlights
August 14, 2023 | finance.yahoo.com
ProMIS Neurosciences Announces Second Quarter 2023 Financial Results and Recent Highlights
August 1, 2023 | seekingalpha.com
PMN ProMIS Neurosciences, Inc.
July 17, 2023 | marketwatch.com
Toronto Stocks Edge Lower; ProMIS Neurosciences Soars on Positive Alzheimer's Treatment Data
July 17, 2023 | msn.com
Alzheimer’s Drug Data Sends ProMIS Vaulting Up
July 17, 2023 | msn.com
Why ProMIS Neurosciences Stock Surged Today
July 17, 2023 | msn.com
ProMIS stock rockets 115% amid preclinical data for Alzheimer's drug
July 17, 2023 | finance.yahoo.com
ProMIS Showcases Preclinical Data at the Alzheimer’s Association International Conference 2023 on Computationally-Derived Antibody and Vaccine from Alzheimer’s Pipeline
July 14, 2023 | finance.yahoo.com
ProMIS Announces Completion of Continuance
July 10, 2023 | finanznachrichten.de
ProMIS Neurosciences Inc.: ProMIS Neurosciences to Consolidate Trading on the Nasdaq Exchange
July 10, 2023 | finance.yahoo.com
ProMIS Neurosciences to Consolidate Trading on the Nasdaq Exchange
June 30, 2023 | finance.yahoo.com
ProMIS Neurosciences Holds Annual Meeting of Shareholders All Resolutions Approved
June 29, 2023 | finance.yahoo.com
CORRECTION: Updated URL to Access ProMIS Annual Meeting of Shareholders on June 29, 2023 at 9:30am Eastern Time
May 16, 2023 | finanznachrichten.de
ProMIS Neurosciences Inc.: ProMIS Neurosciences Announces First Quarter 2023 Financial Results and Recent Highlights
May 8, 2023 | finance.yahoo.com
ProMIS Neurosciences Announces FDA Clearance of Investigational New Drug (IND) Application for PMN310 in Alzheimer’s Disease
April 27, 2023 | theglobeandmail.com
Closing Bell: Promis Neurosciences Inc up on Wednesday (PMN)
See More Headlines
Receive PMN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for ProMIS Neurosciences and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange
TSE
Sector
Medical
Industry
Biotechnology
Sub-Industry
N/A
Current Symbol
TSE:PMN
Previous Symbol
TSE:AMF
CUSIP
N/A
CIK
N/A
Web
www.promisneurosciences.com
Phone
+1-416-8476898
Fax
N/A
Employees
6
Year Founded
N/A

Profitability

EPS (Most Recent Fiscal Year)
C($3.38)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
C$-20,930,000.00
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-837.71%
Return on Assets
-168.33%

Debt

Debt-to-Equity Ratio
108.33
Current Ratio
0.51
Quick Ratio
1.30

Sales & Book Value

Annual Sales
C$7,558.00
Price / Sales
0.00
Cash Flow
N/A
Price / Cash Flow
14.07
Book Value
C($0.72) per share
Price / Book
N/A

Miscellaneous

Outstanding Shares
8,580,000
Free Float
N/A
Market Cap
C$51.48 million
Optionable
Not Optionable
Beta
1.19
10 Best Cheap Stocks to Buy Now Cover
10 Best Cheap Stocks to Buy Now

MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Click the link below to see which companies made the list.

Get This Free Report

Key Executives

  • Mr. Eugene Williams (Age 64)
    Co-Founder & Chairman
    Comp: $439.21k
  • Dr. Gail M. Farfel Ph.D. (Age 59)
    CEO & Director
    Comp: $177.23k
  • Dr. Neil R. Cashman M.D. (Age 71)
    Founder, Co-Chairman of Scientific Advisory Board, Chief Scientific Officer & Director
    Comp: $333.8k
  • Mr. Gavin T. Malenfant (Age 59)
    Chief Operating Officer
    Comp: $413.49k
  • Mr. Daniel E. Geffken M.B.A. (Age 66)
    MBA, Chief Financial Officer
  • Dr. Johanne Kaplan Ph.D. (Age 63)
    Chief Devel. Officer
  • Dr. Ernest D. Bush Ph.D.
    Head of Pharmacology/Toxicology & Sr. Consultant
  • Dr. David Wishart Ph.D.
    Chief Physics Officer
  • Mr. Dennis Chen Ph.D.
    Head of Manufacturing & Sr. Consultant
  • Dr. Larry Douglas Altstiel M.D. (Age 73)
    Ph.D., Chief Medical Officer

Key Competitors

View All Competitors

PMN Stock Analysis - Frequently Asked Questions

What other stocks do shareholders of ProMIS Neurosciences own?

Based on aggregate information from My MarketBeat watchlists, some companies that other ProMIS Neurosciences investors own include CRISPR Therapeutics (CRSP), Aurora Cannabis (ACB), Biocept (BIOC), Spectra7 Microsystems (SEV), Flexion Therapeutics (FLXN), Onconova Therapeutics (ONTX), TherapeuticsMD (TXMD), Bonavista Energy Co. (BNP.TO) (BNP) and QEP Resources (QEP).

How do I buy shares of ProMIS Neurosciences?

Shares of PMN stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

This page (TSE:PMN) was last updated on 4/18/2024 by MarketBeat.com Staff

From Our Partners
[Urgent!] Generational Wealth Gameplan
Crypto 101 Media
The “Perfect Storm” for Gold
Gold Safe Exchange
Biden’s $374B Giveaway Into This Sector
DTI
Forget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THIS
Paradigm Press
Did You Get Your Free Bitcoin Yet?
Crypto Swap Profits
Your Money is Not Safe
American Alternative
The Next Nvidia?
InvestorPlace
How Biden has already won 2024
Porter & Company